M L71 (Letrozole 2.5 mg)
Pill imprint M L71 has been identified as Letrozole 2.5 mg.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant; female infertility and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M L71 (Letrozole 2.5 mg)
Letrozole
- Imprint:
-
M
L71 - Strength:
- 2.5 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2071
More resources
Letrozole is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
